Tegaserod
Products Tegaserod (Zelmac, Zelnorm, tablets) was approved in many countries in 2001. After showing an increased risk of ischemic cardiovascular events such as heart attack and stroke, Novartis withdrew the drug from the market in 2007 on orders from Swissmedic. Structure and properties Tegaserod (C16H23N5O, Mr = 301.4 g/mol) exists as tegaserodmaleate, a white crystalline … Tegaserod
